DCTHDelcath Systems Inc
DCTH
Delcath Systems Inc26,257
Mkt Cap
$396.31MVolume
569,736.0052W High
$18.2352W Low
$8.12PE Ratio
1,913.33DCTH Fundamentals
Price
$11.48Prev Close
$11.24Open
$11.3650D MA
$9.95Beta
1.28Avg. Volume
277,905.19EPS (Annual)
$0.0676P/B
3.51Rev/Employee
$546,352.56$313.09
Compact View
Not available
Not available
Poll
Earnings Recap
• Reported GAAP EPS of -$0.03 down -200.00% YoY • Reported revenue of $24.99M up 26.33% YoY • Delcath Systems forecasts 2026 total revenue of at least $100M, with HEPZATO KIT volume increasing over 20% from 2025. The company expects gross margins of 84% to 87% and positive adjusted EBITDA.
Bullish
Delcath Systems saw total revenue increase to $25M, driven by 36% HEPZATO volume growth and 29 active centers. The company also secured CHEMOSAT inclusion in a key clinical guideline.
Bearish
Delcath Systems reported a net loss of $1.1M and decreased adjusted EBITDA to $3.4M. The company also experienced increased research and development, and selling, general and administrative expenses.